AstraZeneca
AZN
#61
Rank
NZ$475.20 B
Marketcap
NZ$306.41
Share price
0.85%
Change (1 day)
25.81%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.96

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.91. In 2024 the company made an earnings per share (EPS) of NZ$7.78 an increase over its 2023 EPS that were of NZ$6.58.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.96
2024NZ$7.7818.23%
2023NZ$6.5881.13%
2022NZ$3.63631.03%
2021NZ$0.50-88.11%
2020NZ$4.18136.89%
2019NZ$1.77-39.41%
2018NZ$2.91-28.27%
2017NZ$4.06-14.37%
2016NZ$4.7424.11%
2015NZ$3.82127.55%
2014NZ$1.68-51.96%
2013NZ$3.50-58.95%
2012NZ$8.52-32.2%
2011NZ$12.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.97 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.03 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.19-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.38 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.39-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.03 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.10-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.10-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.66-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK